UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 244

Sortiert nach

Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial

Alimentary pharmacology & therapeutics, 2017-07, Vol.46 (2), p.142-149

2017

Volltextzugriff (PDF)

The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction

Annals of the rheumatic diseases, 2006-07, Vol.65 (7), p.905-909

2006

Volltextzugriff (PDF)

Calcium Pyrophosphate Deposition Disease Arthropathy–Related Sciatica

Arthritis & rheumatology (Hoboken, N.J.), 2019-12, Vol.71 (12), p.2099-2099

2019

Volltextzugriff (PDF)

Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2015-07, Vol.9 (7), p.525-531

2015

Volltextzugriff (PDF)

Reference microarchitectural values measured by HR-pQCT in a Franco-Swiss cohort of young adult women

Osteoporosis international, 2022-03, Vol.33 (3), p.703-709

2022

Volltextzugriff (PDF)

The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region

Annals of the rheumatic diseases, 2015-08, Vol.74 (8), p.e40-e40

2015

Volltextzugriff (PDF)

New‐onset vitiligo and progression of pre‐existing vitiligo during treatment with biological agents in chronic inflammatory diseases

Journal of the European Academy of Dermatology and Venereology, 2017-01, Vol.31 (1), p.181-186

2017

Volltextzugriff (PDF)

Assessment of hand bone loss in rheumatoid arthritis by high-resolution peripheral quantitative CT

Annals of the rheumatic diseases, 2010-09, Vol.69 (9), p.1671-1676

2010

Volltextzugriff (PDF)

AB0695 Bone Quality Assessment by The Trabecular Bone Score in Spondyloarthritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1142-1142

2016

Volltextzugriff (PDF)

FRI0180 No Prediction of Relapse by TNF Blocker Concentrations or Detection of Antibodies against anti-TNF: Data from Strass Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.495-495

2016

Volltextzugriff (PDF)

Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis

Annals of the rheumatic diseases, 2009-08, Vol.68 (8), p.1328-1333

2009

Volltextzugriff (PDF)

A 3-year back and forth between Modic type 1 and 2 on MRI in chronic low back pain

Joint, bone, spine : revue du rhumatisme, 2019-01, Vol.86 (1), p.109-110

2019

Volltextzugriff (PDF)

FRI0109 Methotrexate Reduced TNF Bioactivity by Anti-Infliximab Antibody Prevention in Rheumatoid Arthritis Patients Treated with Infliximab

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.459-459

2015

Volltextzugriff (PDF)

Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service

Osteoporosis international, 2015-12, Vol.26 (12), p.2869-2875

2015

Volltextzugriff (PDF)

Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus

Rheumatology (Oxford, England), 2007-01, Vol.46 (1), p.97-99

2007

Volltextzugriff (PDF)

FRI0372 Factors Associated with Persistent Fatigue in Patients with RA or AXSPA with Low Disease Activity Under Biological DMARDS

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.561-561

2015

Volltextzugriff (PDF)

A Consensus Method for Determining Volumetric Joint Space Width in Finger Joints of Arthritis Patients Using HR-PQCT

Osteoarthritis and cartilage, 2017-04, Vol.25, p.S233-S234

2017

Volltextzugriff (PDF)

AB0457 Longitudinal study of serum TNF alpha levels, infliximab, and antibodies to infliximab in rheumatoid arthritis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.663-663

2013

Volltextzugriff (PDF)

Early occupational therapy programme increases hand grip strength at 3 months: results from a randomised, blind, controlled study in early rheumatoid arthritis

Annals of the rheumatic diseases, 2009-03, Vol.68 (3), p.400-403

2009

Volltextzugriff (PDF)

SAT0132 Severe periodontal disease associated with severe rheumatoid arthritis is a predictive factor for clinical infliximab response

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.515-515

2013

Volltextzugriff (PDF)

THU0164 Tnf-Alpha Bioactivity: A New Biomarker of Aspa Activity in Patients with Tnf-Alpha Blockers

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.237-237

2014

Volltextzugriff (PDF)

Effects of infliximab therapy on biological markers of synovium activity and cartilage breakdown in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2009-07, Vol.68 (7), p.1197-1200

2009

Volltextzugriff (PDF)

Rituximab-related late-onset neutropenia in a patient with severe rheumatoid arthritis

Annals of the rheumatic diseases, 2008-06, Vol.67 (6), p.893-894

2008

Volltextzugriff (PDF)

THU0159 Beneficial Effect of Methotrexate in Combination with a Biotherapy for the Long Maintenance of Biotherapy in RA Patients

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A217-A217

2013

Volltextzugriff (PDF)

Lupus erythematosus with leflunomide: induction or reactivation?

Annals of the rheumatic diseases, 2005-01, Vol.64 (1), p.153-155

2005

Volltextzugriff (PDF)

1 – 25 von 244

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(191)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(93)
Science & Technology
(72)
Life Sciences & Biomedicine
(59)
Female
(50)
Male
(48)
Adult
(39)
Middle Aged
(38)
Biological And Medical Sciences
(33)
Rheumatology
(29)
Medical Sciences
(27)
Aged
(25)
Animals
(21)
Rheumatoid Arthritis
(18)
Diseases Of The Osteoarticular System
(15)
Life Sciences
(14)
Inflammatory Joint Diseases
(13)
General & Internal Medicine
(10)
Space Life Sciences
(10)
Physical Sciences
(9)
Infliximab
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial

The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction

Calcium Pyrophosphate Deposition Disease Arthropathy–Related Sciatica

Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease

Reference microarchitectural values measured by HR-pQCT in a Franco-Swiss cohort of young adult women

The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region

New‐onset vitiligo and progression of pre‐existing vitiligo during treatment with biological agents in chronic inflammatory diseases

Assessment of hand bone loss in rheumatoid arthritis by high-resolution peripheral quantitative CT

AB0695 Bone Quality Assessment by The Trabecular Bone Score in Spondyloarthritis

FRI0180 No Prediction of Relapse by TNF Blocker Concentrations or Detection of Antibodies against anti-TNF: Data from Strass Study

Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis

A 3-year back and forth between Modic type 1 and 2 on MRI in chronic low back pain

FRI0109 Methotrexate Reduced TNF Bioactivity by Anti-Infliximab Antibody Prevention in Rheumatoid Arthritis Patients Treated with Infliximab

Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service

Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus

FRI0372 Factors Associated with Persistent Fatigue in Patients with RA or AXSPA with Low Disease Activity Under Biological DMARDS

A Consensus Method for Determining Volumetric Joint Space Width in Finger Joints of Arthritis Patients Using HR-PQCT

AB0457 Longitudinal study of serum TNF alpha levels, infliximab, and antibodies to infliximab in rheumatoid arthritis

Early occupational therapy programme increases hand grip strength at 3 months: results from a randomised, blind, controlled study in early rheumatoid arthritis

SAT0132 Severe periodontal disease associated with severe rheumatoid arthritis is a predictive factor for clinical infliximab response

THU0164 Tnf-Alpha Bioactivity: A New Biomarker of Aspa Activity in Patients with Tnf-Alpha Blockers

Effects of infliximab therapy on biological markers of synovium activity and cartilage breakdown in patients with rheumatoid arthritis

Rituximab-related late-onset neutropenia in a patient with severe rheumatoid arthritis

THU0159 Beneficial Effect of Methotrexate in Combination with a Biotherapy for the Long Maintenance of Biotherapy in RA Patients

Lupus erythematosus with leflunomide: induction or reactivation?

Suchergebnisse filtern